Last edition
News about "Antimicrobial Peptide"
Qnovia Secures Global License for Novel Antimicrobial Peptide to Combat Drug-Resistant Infections
Qnovia has obtained worldwide exclusive rights from the University of Virginia to develop and commercialise the D8 antimicrobial peptide, a novel therapy designed to target multidrug-resistant bacterial infections through a unique mechanism.
Antimicrobial Peptide | 31/07/2026 | By News Bureau
Omnix Medical has initiated patient dosing in its Phase 2 clinical trial of OMN6, a novel antimicrobial peptide designed to treat severe multidrug-resistant Acinetobacter baumannii infections, a critical global health threat with limited treatment options.
Antimicrobial Peptide | 05/06/2026 | By News Bureau | 132
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy